iconstar paper   HIV Articles  
Back grey arrow rt.gif
 
 
Euro Resist Wk: Resistance Post Week 48 in ART-Experienced, Integrase Inhibitor-Naïve Subjects with Dolutegravir (DTG) vs. Raltegravir (RAL) in SAILING (ING111762) (oral slides)
 
 
  Reported by Jules Levin
13th European HIV & Hepatitis Workshop; June 3-5, 2015; Barcelona, Spain
 
MR Underwood1, F DeAnda1, D Dorey2, K Hightower1, R Wang1, S Griffith1, J Horton3
1 GlaxoSmithKline, North Carolina, USA, 2 GlaxoSmithKline, Mississauga, ON, Canada. 3 Currently PAREXEL International (previously GlaxoSmithKline, North Carolina, USA.)

HCV1.gif

HCV2.gif

HCV3.gif

HCV4.gif

HCV5.gif

HCV6.gif

HCV7.gif

HCV8.gif

HCV9.gif

 
 
 
 
  iconpaperstack View Older Articles   Back to Top   www.natap.org